739 CLINICAL CHARACTERISTICS OF VON HIPPEL-LINDAU DISEASE IN CHINESE PATIENTS
Kan Gong,Pengjie Wu,Ning Zhang,Xi Wang,Xianghui Ning,Teng Li,Dingfang Bu
DOI: https://doi.org/10.1016/j.juro.2013.02.302
2013-01-01
Abstract:You have accessJournal of UrologyKidney Cancer: Evaluation & Staging (II)1 Apr 2013739 CLINICAL CHARACTERISTICS OF VON HIPPEL-LINDAU DISEASE IN CHINESE PATIENTS Kan Gong, Pengjie Wu, Ning Zhang, Xi Wang, Xianghui Ning, Teng Li, and Dingfang Bu Kan GongKan Gong Beijing, China, People's Republic of More articles by this author , Pengjie WuPengjie Wu Beijing, China, People's Republic of More articles by this author , Ning ZhangNing Zhang Beijing, China, People's Republic of More articles by this author , Xi WangXi Wang Beijing, China, People's Republic of More articles by this author , Xianghui NingXianghui Ning Beijing, China, People's Republic of More articles by this author , Teng LiTeng Li Beijing, China, People's Republic of More articles by this author , and Dingfang BuDingfang Bu Beijing, China, People's Republic of More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2013.02.302AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES von Hippel-Lindau (VHL) disease is the most common hereditary renal cell carcinoma. It is an autosomal dominant familial cancer syndrome caused by VHL gene mutation. Here we were to study the clinical characteristics of VHL disease in China. METHODS From July 2009 to October 2012, all patients diagnosed with VHL disease based on the clinical diagnosis criteria were tested for VHL germline mutations as well their relatives. PCR-direct sequencing was used to detect intragenic mutation, and universal primer quantitative fluorescent multiplex PCR (UPQFM-PCR) was used to detect VHL large deletion. RESULTS All the 36 patients clinically diagnosed with VHL disease had VHL mutation. PCR-direct sequencing detected 28 (77.8%, 28/36) probands with germline mutations. UPQFM-PCR found 8 (22.2%, 8/36) large deletions. Remarkably, there were 52.8% (19/36) probands without family history in Chinese VHL disease families. CONCLUSIONS The incidence of VHL large deletions was up to 22.2%. So we should detect VHL large deletions as a routine to improve the ratio of correct diagnosis. Compared with NIH reports, the prevalence rate of probands without family history in China was much higher than Western and Japan (20%∼23%), suggesting high frequency of sporadic (de novo) mutations in China. © 2013 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 189Issue 4SApril 2013Page: e304 Advertisement Copyright & Permissions© 2013 by American Urological Association Education and Research, Inc.Metrics Author Information Kan Gong Beijing, China, People's Republic of More articles by this author Pengjie Wu Beijing, China, People's Republic of More articles by this author Ning Zhang Beijing, China, People's Republic of More articles by this author Xi Wang Beijing, China, People's Republic of More articles by this author Xianghui Ning Beijing, China, People's Republic of More articles by this author Teng Li Beijing, China, People's Republic of More articles by this author Dingfang Bu Beijing, China, People's Republic of More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...